Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation

[1]  Li Lin,et al.  Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis. , 2017, Cancer letters.

[2]  Ram I Mahato,et al.  Recent advances in hepatocellular carcinoma therapy. , 2017, Pharmacology & therapeutics.

[3]  Hongda Liu,et al.  Correlations between TBL1XR1 and recurrence of colorectal cancer , 2017, Scientific Reports.

[4]  Yan Wu,et al.  The mir-675-5p regulates the progression and development of pancreatic cancer via the UBQLN1-ZEB1-mir200 axis , 2017, Oncotarget.

[5]  Ling Wang,et al.  Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment. , 2017, Journal of ethnopharmacology.

[6]  R. Cabrera,et al.  Disease monitoring of hepatocellular carcinoma through metabolomics , 2017, World journal of hepatology.

[7]  Shanshan Wang,et al.  Efficacy of compound Kushen injection plus radiotherapy on nonsmall-cell lungcancer: A systematic review and meta-analysis. , 2016, Journal of cancer research and therapeutics.

[8]  B. Lei,et al.  Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia , 2016, Evidence-based complementary and alternative medicine : eCAM.

[9]  X. Qin,et al.  Kidney Tissue Targeted Metabolic Profiling of Unilateral Ureteral Obstruction Rats by NMR , 2016, Front. Pharmacol..

[10]  David L. Adelson,et al.  Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics , 2016, Oncotarget.

[11]  F. Liu,et al.  Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway , 2016, Oncotarget.

[12]  L. Kong,et al.  Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway , 2016, Scientific Reports.

[13]  Yanqiong Zhang,et al.  Thyroid hormone synthesis: a potential target of a Chinese herbal formula Haizao Yuhu Decoction acting on iodine-deficient goiter , 2016, Oncotarget.

[14]  M. Čuperlović-Culf,et al.  1H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism , 2016, International journal of cancer.

[15]  X. Qin,et al.  Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology , 2016, Scientific Reports.

[16]  Rui-sheng Li,et al.  The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis , 2016, Front. Pharmacol..

[17]  Antonio Lavecchia,et al.  In silico methods to address polypharmacology: current status, applications and future perspectives. , 2016, Drug discovery today.

[18]  Anand Anbarasu,et al.  Gene network analysis reveals the association of important functional partners involved in antibiotic resistance: A report on an important pathogenic bacterium Staphylococcus aureus. , 2016, Gene.

[19]  Xian-Zhong Yan,et al.  Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma , 2015, Scientific Reports.

[20]  Zhong Wang,et al.  System-wide assembly of pathways and modules hierarchically reveal metabolic mechanism of cerebral ischemia , 2015, Scientific Reports.

[21]  Amit G Singal,et al.  Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  Yan-Ling Zhao,et al.  Efficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-Analysis , 2015, Evidence-based complementary and alternative medicine : eCAM.

[23]  Gary D Bader,et al.  Pathway and network analysis of cancer genomes , 2015, Nature Methods.

[24]  X. Qin,et al.  (1)H NMR based metabolomic study of the antifatigue effect of Astragali Radix. , 2014, Molecular bioSystems.

[25]  Na Lin,et al.  A Systems Biology-Based Approach to Uncovering the Molecular Mechanisms Underlying the Effects of Dragon's Blood Tablet in Colitis, Involving the Integration of Chemical Analysis, ADME Prediction, and Network Pharmacology , 2014, PloS one.

[26]  A. Lane,et al.  Fructose-2,6-Bisphosphate synthesis by 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth , 2014, Oncotarget.

[27]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[28]  Shao Li,et al.  A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. , 2014, Molecular bioSystems.

[29]  Xiaofeng Liu,et al.  ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method , 2013, Bioinform..

[30]  Bo Zhang,et al.  An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin , 2013, Evidence-based complementary and alternative medicine : eCAM.

[31]  Zhao Fang,et al.  TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..

[32]  Wei Gao,et al.  RNAi silencing of c-Myc inhibits cell migration, invasion, and proliferation in HepG2 human hepatocellular carcinoma cell line: c-Myc silencing in hepatocellular carcinoma cell , 2013, Cancer Cell International.

[33]  Michael V. Fiandalo,et al.  Caspase control: protagonists of cancer cell apoptosis. , 2012, Experimental oncology.

[34]  M. Martinka,et al.  MMP2 expression is a prognostic marker for primary melanoma patients , 2012, Cellular Oncology.

[35]  Chi V Dang,et al.  Links between metabolism and cancer. , 2012, Genes & development.

[36]  Takashi Tsukamoto,et al.  Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. , 2012, Cell metabolism.

[37]  J. Uhm.  IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype , 2012 .

[38]  Jong Bhak,et al.  Liverome: a curated database of liver cancer-related gene signatures with self-contained context information , 2011, BMC Genomics.

[39]  Franziska Hirschhaeuser,et al.  Lactate: a metabolic key player in cancer. , 2011, Cancer research.

[40]  R. Rossignol,et al.  Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? , 2011, Biochimica et biophysica acta.

[41]  M. Pruschy,et al.  Metabolism of tumors under treatment: mapping of metabolites with quantitative bioluminescence. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  Calvin Yu-Chian Chen,et al.  TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.

[43]  Hao Ye,et al.  HIT: linking herbal active ingredients to targets , 2010, Nucleic Acids Res..

[44]  Lewis R. Roberts,et al.  Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.

[45]  Gary D. Bader,et al.  Cytoscape Web: an interactive web-based network browser , 2010, Bioinform..

[46]  C. Widmann,et al.  Glucose metabolism in cancer cells , 2010, Current opinion in clinical nutrition and metabolic care.

[47]  Jing Gao,et al.  Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks , 2010, Bioinform..

[48]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[49]  David S. Wishart,et al.  HMDB: a knowledgebase for the human metabolome , 2008, Nucleic Acids Res..

[50]  Christian von Mering,et al.  STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..

[51]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[52]  S. Boyault,et al.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets , 2007, Hepatology.

[53]  Jing Li,et al.  New Bioinformatics Resources For Metabolomics , 2006, Pacific Symposium on Biocomputing.

[54]  Wen-Hui Su,et al.  OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci , 2006, Nucleic Acids Res..

[55]  Gopal R. Gopinath,et al.  Reactome: a knowledge base of biologic pathways and processes , 2007, Genome Biology.

[56]  Hidde de Jong,et al.  Genetic Network Analyzer: qualitative simulation of genetic regulatory networks , 2003, Bioinform..

[57]  S. Anant,et al.  Expression of the Regenerating Gene Family in Inflammatory Bowel Disease Mucosa: Reg Iα Upregulation, Processing, and Antiapoptotic Activity , 2002, Journal of Investigative Medicine.

[58]  G. Giannelli,et al.  Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinoma , 2002, International journal of cancer.

[59]  G. Thomas,et al.  Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. , 2001, Gastroenterology.

[60]  T. Roskams,et al.  Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells. , 1999, The American journal of pathology.

[61]  L. Christa,et al.  A novel gene (HIP) activated in human primary liver cancer. , 1992, Cancer research.